Matches in SemOpenAlex for { <https://semopenalex.org/work/W3082286918> ?p ?o ?g. }
- W3082286918 endingPage "1716" @default.
- W3082286918 startingPage "1704" @default.
- W3082286918 abstract "To provide guidance about management of psoriatic disease during the coronavirus disease 2019 (COVID-19) pandemic.A task force (TF) of 18 physician voting members with expertise in dermatology, rheumatology, epidemiology, infectious diseases, and critical care was convened. The TF was supplemented by nonvoting members, which included fellows and National Psoriasis Foundation (NPF) staff. Clinical questions relevant to the psoriatic disease community were informed by questions received by the NPF. A Delphi process was conducted.The TF approved 22 guidance statements. The average of the votes was within the category of agreement for all statements. All guidance statements proposed were recommended, 9 with high consensus and 13 with moderate consensus.The evidence behind many guidance statements is limited in quality.These statements provide guidance for the management of patients with psoriatic disease on topics ranging from how the disease and its treatments impact COVID-19 risk and outcome, how medical care can be optimized during the pandemic, what patients should do to lower their risk of getting infected with severe acute respiratory syndrome coronavirus 2 and what they should do if they develop COVID-19. The guidance is intended to be a living document that will be updated by the TF as data emerge." @default.
- W3082286918 created "2020-09-08" @default.
- W3082286918 creator A5003552507 @default.
- W3082286918 creator A5003779121 @default.
- W3082286918 creator A5006332537 @default.
- W3082286918 creator A5012215138 @default.
- W3082286918 creator A5014408021 @default.
- W3082286918 creator A5016489941 @default.
- W3082286918 creator A5019280990 @default.
- W3082286918 creator A5023272479 @default.
- W3082286918 creator A5031855679 @default.
- W3082286918 creator A5032924701 @default.
- W3082286918 creator A5033795032 @default.
- W3082286918 creator A5033903141 @default.
- W3082286918 creator A5038505651 @default.
- W3082286918 creator A5047076464 @default.
- W3082286918 creator A5049489990 @default.
- W3082286918 creator A5053676040 @default.
- W3082286918 creator A5058092661 @default.
- W3082286918 creator A5058903008 @default.
- W3082286918 creator A5059153511 @default.
- W3082286918 creator A5064451049 @default.
- W3082286918 creator A5064922993 @default.
- W3082286918 creator A5068543626 @default.
- W3082286918 creator A5071341347 @default.
- W3082286918 creator A5073903998 @default.
- W3082286918 creator A5078867004 @default.
- W3082286918 creator A5080237247 @default.
- W3082286918 creator A5082931235 @default.
- W3082286918 creator A5089866762 @default.
- W3082286918 date "2020-12-01" @default.
- W3082286918 modified "2023-10-14" @default.
- W3082286918 title "National Psoriasis Foundation COVID-19 Task Force Guidance for Management of Psoriatic Disease During the Pandemic: Version 1" @default.
- W3082286918 cites W1815404375 @default.
- W3082286918 cites W1938856372 @default.
- W3082286918 cites W1986879574 @default.
- W3082286918 cites W2004166110 @default.
- W3082286918 cites W2022665587 @default.
- W3082286918 cites W2028621745 @default.
- W3082286918 cites W2063490210 @default.
- W3082286918 cites W2068419991 @default.
- W3082286918 cites W2080172852 @default.
- W3082286918 cites W2095652983 @default.
- W3082286918 cites W2101333519 @default.
- W3082286918 cites W2104675861 @default.
- W3082286918 cites W2105477284 @default.
- W3082286918 cites W2133701923 @default.
- W3082286918 cites W2158162896 @default.
- W3082286918 cites W2223868808 @default.
- W3082286918 cites W2318786110 @default.
- W3082286918 cites W2332704525 @default.
- W3082286918 cites W2588681363 @default.
- W3082286918 cites W2606267946 @default.
- W3082286918 cites W2613397542 @default.
- W3082286918 cites W2748768370 @default.
- W3082286918 cites W2768055286 @default.
- W3082286918 cites W2792992921 @default.
- W3082286918 cites W2897063798 @default.
- W3082286918 cites W2901927288 @default.
- W3082286918 cites W2901986848 @default.
- W3082286918 cites W2912058252 @default.
- W3082286918 cites W2915502547 @default.
- W3082286918 cites W2916841405 @default.
- W3082286918 cites W2921868220 @default.
- W3082286918 cites W2964703987 @default.
- W3082286918 cites W3001897055 @default.
- W3082286918 cites W3002108456 @default.
- W3082286918 cites W3007389533 @default.
- W3082286918 cites W3008827533 @default.
- W3082286918 cites W3012804303 @default.
- W3082286918 cites W3014361071 @default.
- W3082286918 cites W3015090018 @default.
- W3082286918 cites W3015176848 @default.
- W3082286918 cites W3015495837 @default.
- W3082286918 cites W3015607499 @default.
- W3082286918 cites W3017244954 @default.
- W3082286918 cites W3017442647 @default.
- W3082286918 cites W3017577317 @default.
- W3082286918 cites W3018029174 @default.
- W3082286918 cites W3019235900 @default.
- W3082286918 cites W3019291397 @default.
- W3082286918 cites W3019389652 @default.
- W3082286918 cites W3019598142 @default.
- W3082286918 cites W3020611303 @default.
- W3082286918 cites W3020883613 @default.
- W3082286918 cites W3022076331 @default.
- W3082286918 cites W3022148547 @default.
- W3082286918 cites W3022292556 @default.
- W3082286918 cites W3022606024 @default.
- W3082286918 cites W3022878099 @default.
- W3082286918 cites W3023082818 @default.
- W3082286918 cites W3023616880 @default.
- W3082286918 cites W3024016727 @default.
- W3082286918 cites W3024177957 @default.
- W3082286918 cites W3024184170 @default.
- W3082286918 cites W3024193040 @default.
- W3082286918 cites W3025029990 @default.
- W3082286918 cites W3025200871 @default.